PPDTM CorEvitasTM Vitiligo Drug Safety and Effectiveness Registry for Adults & Adolescents
ConditionVitiligo
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age12+
SponsorCorEvitas
About this trial
The design is a prospective, observational (non-interventional) registry for adolescent and adult subjects with NSV under the care of a dermatology provider.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Have a dermatologist- or qualified dermatology practitioner-confirmed diagnosis of nonsegmental vitiligo (NSV).
Is at least 12 years of age or older at the time of enrollment.
Is willing and able to provide informed consent or assent, with parent/legal guardian consent as applicable.
Adult participants are willing and able to provide required personal information
Disqualifiers
None
Trial population
Subjects enrolled in this registry will be treated according to routine clinical care; the assignment of subjects to any treatment will not be determined in advance by the protocol and will be clearly separated from the decision to include subjects in the registry
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Vitiligo Epidemiology and presentation
The major clinical outcome include an assessment of the epidemiology of Vitiligo. This will be determined using PROs and ClinROs which will be included as part of the case report forms.
Time frame
Every 6 months for 10 years] Source ClinicalTrials.gov